JP2016528178A5 - - Google Patents

Download PDF

Info

Publication number
JP2016528178A5
JP2016528178A5 JP2016518421A JP2016518421A JP2016528178A5 JP 2016528178 A5 JP2016528178 A5 JP 2016528178A5 JP 2016518421 A JP2016518421 A JP 2016518421A JP 2016518421 A JP2016518421 A JP 2016518421A JP 2016528178 A5 JP2016528178 A5 JP 2016528178A5
Authority
JP
Japan
Prior art keywords
formulation
extract
formulation according
emulsifier
ethyl acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016518421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016528178A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/040771 external-priority patent/WO2014197520A1/en
Publication of JP2016528178A publication Critical patent/JP2016528178A/ja
Publication of JP2016528178A5 publication Critical patent/JP2016528178A5/ja
Pending legal-status Critical Current

Links

JP2016518421A 2013-06-03 2014-06-03 癌治療のための植物抽出物の新しい製剤 Pending JP2016528178A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361830632P 2013-06-03 2013-06-03
US61/830,632 2013-06-03
PCT/US2014/040771 WO2014197520A1 (en) 2013-06-03 2014-06-03 Novel formulations of botanical extracts for cancer therapy

Publications (2)

Publication Number Publication Date
JP2016528178A JP2016528178A (ja) 2016-09-15
JP2016528178A5 true JP2016528178A5 (enExample) 2017-07-13

Family

ID=52008545

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016518421A Pending JP2016528178A (ja) 2013-06-03 2014-06-03 癌治療のための植物抽出物の新しい製剤

Country Status (7)

Country Link
US (1) US20160143970A1 (enExample)
EP (1) EP3003334A4 (enExample)
JP (1) JP2016528178A (enExample)
CN (1) CN105705153A (enExample)
CA (1) CA2953283A1 (enExample)
SG (1) SG11201510804UA (enExample)
WO (1) WO2014197520A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220142214A1 (en) * 2020-11-11 2022-05-12 StemSation USA, Inc. Synergistic composition of food-based and organic nutrients and methods for use and manufacture
CN116763777A (zh) * 2022-03-09 2023-09-19 四川育强本草生物技术有限公司 17-氢-9-去氢穿心莲内酯-19-硫酸酯钠在制备治疗奶牛乳房炎的药物中的用途
CN114617088A (zh) * 2022-03-14 2022-06-14 海南金雨海洋产业发展有限公司 一种提高东风螺免疫力的养殖方法
CN114875027B (zh) * 2022-05-11 2024-09-24 澳门科技大学 双链rna分子及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
EP1374880B1 (en) * 2001-04-02 2006-03-08 Hongfen Li An antineoplastic drug
PL1663103T3 (pl) * 2003-09-08 2012-05-31 Genyous Biomed Int Inc Kompozycje roślinnych ekstraktów do leczenia nowotworu
CN1795875A (zh) * 2004-12-21 2006-07-05 董英杰 莪术油脂肪乳剂及制备方法
US20110117121A1 (en) * 2006-10-27 2011-05-19 James Dao Compositions for treatment and inhibition of pain
EP2635127B1 (en) * 2010-11-04 2018-10-17 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and bicalutamide

Similar Documents

Publication Publication Date Title
胡兴胜 et al. 培美曲塞及吉西他滨分别联合顺铂治疗初治晚期非小细胞肺癌安全性和有效性的随机对照研究
JP2016528178A5 (enExample)
Atiq et al. Anti-neoplastic potential of flavonoids and polysaccharide phytochemicals in glioblastoma
JP2007505042A5 (enExample)
RU2006111441A (ru) Композиции растительных экстрактов для лечения рака
JP2010180210A5 (enExample)
WO2016161342A3 (en) Nitrobenzyl derivatives of anti-cancer agents
CN103356515A (zh) 一种大黄素类蒽醌衍生物在制备抗肝癌药物中的应用
JP2016523849A5 (enExample)
JP2016528178A (ja) 癌治療のための植物抽出物の新しい製剤
Sanyal et al. Anti-cancer property of Lenzites betulina (L) Fr. on cervical cancer cell lines and its anti-tumor effect on HeLa-implanted mice
Singh et al. Dawn of antioxidants and immune modulators to stop HIV-progression and boost the immune system in HIV/AIDS patients: An updated comprehensive and critical review
Sur et al. A Comprehensive Review of the Use of Antioxidants and Natural Products in Cancer Patients Receiving Anticancer Therapy
Şekerler et al. In vitro antihepatocellular carcinoma activity of secondary metabolites of Centaurea kilaea Boiss.
CN101455652B (zh) 蓝萼香茶菜中二萜类化合物在制备抗癌药物中的应用
CN103735653B (zh) 一种具有抗肿瘤活性的中药提取物及其制备方法和用途
Li et al. Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer
Han et al. Cantharidin combined with chemotherapy for Chinese patients with metastatic colorectal cancer
Fodouop et al. Bioactivity and therapeutic potential of plant extracts in cancer and infectious diseases
US11607384B2 (en) Lipid emulsified drug delivery systems for chemoprevention and treatment
Xingsheng et al. Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer
Datta et al. Natural Products as Chemosensitizers for Adjunct Therapy in Cancer Management
CN103961353B (zh) 黄芩素与10-羟基喜树碱的药物组合物及其应用
CN103479613A (zh) 氟代紫杉烷类衍生物在制备治疗肝癌药物中的用途
El-Mowafy Phytomedicines: far beyond cytotoxicity in cancer therapy. sole multitarget polypharmacology, chemopreventive and safety profiles: combinatorial synergy, chemosensitization and mitigation of chemotherapy adverse-reactions